Ключевые слова:
ko‘p sonli miyeloma, pnevmoniya, tashxis,antibiotiklar, qo‘zg‘atuvchilar, yallig‘lanish o‘chog‘i, bakterial infeksiyalar, davolash.Библиографические ссылки
Effektivnost bortezomiba pri lechenii bolnix retsidiviruyushey i refrakternoy mnojestvennoy miyelomoy (analiz Rossiyskix dannix issledovaniya eVOBS) / KM.Abdulkadirov [i dr.] // Gematol. i transfuziol. 2012. №3. S.22-25.
Alekseyev G.A., Andreyeva N.YE. Miyelomnaya bolezn. M.: Meditsina, 1966. 245 s.
Andreyeva N.YE, Balakireva T.V. Paraproteinemi-cheskiye gemoblastozi // Rukovodstvo po gematologii: v 3-x t. T.2. / pod red. A.I.Vorobyeva. M.: Nyudiamed, 2003. S. 151-184.
Bessmelsev S.S., Abdulkadirov K.M. Mnojestvennaya miyeloma. SPb.: Dialekt, 2004. 446 s.
Voyno-Yasenetskaya O.V. Legochno-alveolyarniy paraproteinoz u bolnix miyelomnoy boleznyu // Probl. gematol. 1975. №10. S.32-35.
Analiz rezultatov lecheniya bolnix mnojestvennoy miyelomoy / V.V.Voytsexovskiy [i dr.] // Dal-nevost. med. jurn. 2007. №1. S.47-50.
Voytsexovskiy V.V., Landishev Y.S., Grigorenko A.A. Bronxolegochniye oslojneniya xronicheskogo lim-foleykoza i mnojestvennoy miyelomi. Blagoveshensk: Zeya, 2010. 254 s.
Narusheniye endobronxialnoy mikrogemotsirkulyatsii u bolnix mnojestvennoy miyelomoy / V.V.Voytsexovskiy [i dr.] // Dalnevost. med. jurn. 2010; 2:30-33.
Analiz infeksionnix oslojneniy gemoblasto-zov v Amurskoy oblasti / V.V.Voytsexovskiy [i dr.] // Byup. fiziol. i patol. dixaniya. 2012. Vip.46. S.64—68.
Votyakova O.M., Demina YE.A. Mnojestvennaya miyeloma // Klinicheskaya onkogematologiya / pod red. M.A.Volkovoy, 2-ye izd. M.: Meditsina, 2007. S.847-871.
Mendeleyeva L.P., Pokrovskaya L.P. Protokol diagnostiki i lecheniya mnojestvennoy miyelomi // Programmnoye lecheniye zabolevaniy sistemi krovi / pod red. V.G.Savchenko. M., 2012. S.515-578.
Rukavitsin O.A., Sidorovich G.I. Mnojestvennaya miyeloma i rodstvenniye zabolevaniya. M.: BINOM, 2006. 212 s.
Rukavitsin O.A., Sidorovich G.I. Paraprotei-nemicheskiye gemoblastozi. M.: GEOTAR-Media, 2008. 304 s.
Thalidomide, dexamethasone, and pegy-lated liposomal doxorubicin (ThaDD) for patients older than 65 years with newly diagnosed multiple myeloma / M.Offi-dani [etal.] //Blood. 2006. Vol.108, №7. P.2159-2164.
Lenalidomide plus high-dose dexamethasone versus Lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomized controlled trial / S.V.Rajkumar [et al.] // Lancet Oncol. 2010. Vol.ll, №1. P.29-37.